Health Canada reviewing MS drug Gilenya, linked to 11 deaths outside Canada

TORONTO - Health Canada is reviewing a new multiple sclerosis drug that has been linked to 11 deaths. There have been no reports of deaths in Canada of people taking the Novartis drug, which is sold under the brand name Gilenya....More